Imunon, Inc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-06-08

Reporting Person: Pellizzari Christine A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-08	Option to Purchase Celsion Corporation Common Stock	$1.25	A	40000	Acquired	2031-06-08	Celsion Corporation Common Stock (40000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The options vest as follows: 1/3 on January 1, 2022; 1/3 on January 1, 2023; and 1/3 on January 1, 2024.